New Drug Cuts Heart Attack Risk 31% by Fighting Inflammation

One in four people hospitalized for heart attacks has none of the usual risk factors, and their outcomes are often the worst.

For decades, doctors focused on controlling blood pressure, cholesterol, smoking, and diabetes to prevent heart disease. But cardiologist Paul Ridker at Brigham and Women's Hospital in Boston noticed something troubling: perfectly healthy patients kept dying from heart attacks anyway.

After years of research, Ridker and fellow scientists found the missing link. Chronic inflammation, where the immune system attacks the body's own tissues, may be silently driving cardiovascular disease even when cholesterol and blood pressure look normal.

Here's what happens inside your arteries. When cholesterol builds up, it changes shape into something your body no longer recognizes. Your immune system treats it like an invader and launches an attack, damaging blood vessels in the process. The result is heart attacks and strokes.

"Heart disease is a disease of inflammation," says Kathryn Moore, director of the Cardiovascular Research Center at New York University. The American College of Cardiology agreed, recommending in fall 2025 that doctors routinely screen patients for inflammatory proteins.

The discovery brought new hope for treatment. In June 2023, the FDA approved colchicine, an inexpensive gout medication, to treat heart disease patients. A 2020 clinical trial showed the drug reduced heart attacks, strokes, and complications by 31 percent, mostly in patients already taking cholesterol medications.

The Bright Side

This breakthrough means doctors can now help the 230,000 Americans who die each year from unexplained heart disease. The inflammation screening tests are simple blood draws, and colchicine costs just pennies per dose compared to expensive newer medications.

Researchers are already testing other anti-inflammatory therapies with even more precise targeting. Some recent colchicine studies haven't shown the same protective effects, so scientists want options that work for everyone.

The shift in thinking transforms how we understand heart health. Your cardiovascular system isn't just a series of clogged pipes that need clearing. It's a complex battlefield where calming inflammation could save millions of lives.

Ridker remembers the moment he realized there had to be another cause beyond the standard risk factors. After dozens of studies and clinical trials, he finally found it hiding in plain sight inside our own immune systems.

Millions of hearts will keep beating because scientists refused to accept that one in four deaths had no explanation.